Testing iodine uptake after a low-iodine diet
Part of Cancer clinical trials.
This study looks at how much iodine your body absorbs after you follow a low-iodine diet before radioactive iodine treatment (131I) for thyroid cancer. It may help improve how safely and effectively this treatment is planned.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- Have a diagnosis of differentiated thyroid cancer (DTC) and be planning 131I ablation therapy
- Follow a low-iodine diet (LID) before the 131I treatment, based on the Dutch DTC guideline
- Be able to follow the study steps and instructions
- Be able to read and understand Dutch
- For the study, do not be pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways of replacing thyroid hormone after radioactive iodine therapy for high-risk thyroid cancer. It aims to find which approach is more effective and better for patients.
This trial tests if a standard radioactive iodine treatment can help people with a type of thyroid cancer (called differentiated thyroid cancer) who have signs of the disease returning after their first treatment. It aims to see if this treatment can control the cancer and improve outcomes.
This study looks at whether certain cancer “targeted therapy” medicines can make radioactive iodine (RAI) therapy work better for thyroid cancer that has spread to the lungs. It also involves taking special whole-body scans to measure how much radioactive iodine gets taken up by the cancer.
This trial tests whether a medicine called recombinant human thyroid stimulating hormone (rhTSH) can help prepare your body for radioactive iodine (131I) treatment, which aims to destroy any remaining or spreading thyroid cancer cells. It may be a good option if your thyroid cancer has come back or spread and you are able to have radioactive iodine therapy.
This trial tests how much radiation a specialized whole-body PET/CT scan delivers in patients with differentiated thyroid cancer. It may help doctors better plan treatment for cancer that persists, returns, or has spread—especially when radioactive iodine (RAI) may or may not work.
This study tests if a man-made hormone (rhTSH) can make radioactive iodine therapy more effective for people with advanced thyroid cancer that has come back or spread. It aims to see if it helps find and treat cancer that doesn't respond well to standard radioactive iodine.
Hear when a new Differentiated Thyroid Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.